Xeljanz

Xeljanz and Xeljanz XR (tofacitinib) are aimed at reducing psoriatic arthritis inflammation. Xeljanz targets a specific part of the immune system (Janus kinase) to reduce the overactive response associated with psoriatic disease. The oral treatment also aids in reducing joint tenderness and swelling.

What is Xeljanz?

How Is Xeljanz Used?

Xeljanz is taken by mouth twice daily as a pill. Xeljanz XR is an extended release formula of the same treatment and is taken by mouth once daily as a pill.

What Are the Risks?

Xeljanz/Xeljanz XR may raise your risk for:

  • High lipid levels
  • High liver enzymes
  • Low blood count
  • Lymphoma and other malignancies
  • Gastrointestinal perforations

Common Side Effects

In clinical trials, the most common side effects were headaches, diarrhea and upper respiratory infections.

Learn More About Your Treatment Options

The Patient Navigation Center is here to provide personalized information about your psoriasis and psoriatic arthritis treatment.

Contact a Patient Navigator today

Stay in the Know.

Expert tips, can’t-miss events and the latest news, straight to your inbox.

National Health Council Standards of ExcellenceCharity NavigatorMy Psoriasis Team logo

Copyright © 1996-2020 National Psoriasis Foundation/USA


Duplication, rebroadcast, republication or other use of content appearing on this website is prohibited without written permission of the National Psoriasis Foundation (NPF).


NPF does not endorse or accept any responsibility for the content of external websites.


NPF does not endorse any specific treatments or medications for psoriasis and psoriatic arthritis.

We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.